More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$481952995
EPS
0.57
P/E ratio
8.8
Price to sales
2.06
Dividend yield
--
Beta
2.202864
Previous close
$5.75
Today's open
$5.64
Day's range
$5.48 - $5.78
52 week range
$3.57 - $6.50
show more
CEO
Robert S. Wiesenthal
Employees
332
Headquarters
New York, NY
Exchange
NASDAQ Capital Market
Shares outstanding
86526570
Issue type
Common Stock
Industrials
Transportation
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
Network of experienced transplant surgeons in key markets will immediately become available to all Strata customers Adds significant scale to Transplant Clinical, Strata's fastest growing business line, with a similar, rapid growth trajectory $21.5 million acquisition completed at mid-single-digit multiple of Adjusted EBITDA, pre-synergy, consistent with Strata's capital deployment strategy NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that it has completed the acquisition of Heart and Lung Transplant National Recovery Program (“HLT-NRP”), a provider of transplant surgical recovery services in the United States. “HLT-NRP strengthens our organ recovery platform by significantly increasing our network of experienced transplant surgeons available to complete recoveries across the country adding clinical depth and geographic reach in key markets such as Florida and California,” said Will Heyburn, Co-CEO of Strata.
GlobeNewsWire • 15 hours ago

Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Investment Research • Jun 16, 2026

Strata Acquires Louisville Perfusion Services
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that it has completed the acquisition of Louisville Perfusion Services, Inc. (“LPS”), a regional provider of perfusion and blood management services to cardiac surgery programs in Kentucky. “The acquisition of Louisville Perfusion Services fits perfectly with our existing customer base in Kentucky and Ohio, giving us a new strategic stronghold in the Midwest and Southern United States,” said Lou Verdetto, CEO of Strata's Clinical Division.
GlobeNewsWire • Jun 2, 2026

AIAI Holdings Corporation Announces Appointment of Board of Directors
Directors bring a strong combination of technology, healthcare, national security, leadership experience, and financial and capital markets backgrounds AIAI Expected to Begin Trading on May 14, 2026 DALLAS, TX / ACCESS Newswire / May 12, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI to enhance portfolio performance, today announced the appointment of the Company's Board of Directors. John P. Rochon leads the 10-person Board as Chairman.
Accesswire • May 12, 2026

Strata Critical Medical Announces Expiration of Warrants
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), announced that its warrants, both the Public Warrants (Nasdaq: SRTAW) and the Private Placement Warrants, expired in accordance with their original terms at 5:00 p.m. Eastern Time today May 7, 2026.
GlobeNewsWire • May 7, 2026

Strata Critical Medical Announces First Quarter 2026 Results
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced financial results for the first quarter ended March 31, 2026. Financial results in this release, including all comparisons to prior year periods, reflect continuing operations only. The results of the divested Passenger business have been reclassified as discontinued operations in all periods.
GlobeNewsWire • May 6, 2026

Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
Seeking Alpha • May 6, 2026

Strata Acquires Ohio Valley Perfusion Associates
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today announced that it has completed the acquisition of Ohio Valley Perfusion Associates ("OVPA"), a regional provider of perfusion services to cardiac surgery programs in Ohio and Pennsylvania. “Expanding our presence in Eastern Ohio and Western Pennsylvania is an important step in strengthening Strata's regional clinical platform,” said Louis Verdetto, CEO of Strata's Clinical Services Division.
GlobeNewsWire • Apr 30, 2026

Strata Critical Medical Schedules First Quarter 2026 Earnings Conference Call
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the first quarter ended March 31, 2026 on Wednesday May 6, 2026 before the market opens.
GlobeNewsWire • Apr 20, 2026

Strata Critical Medical to Present at the 25th Annual Needham Virtual Healthcare Conference
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), today announced that management will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026, at 1:30 pm ET. A webcast of the event will be available at the link here.
GlobeNewsWire • Apr 9, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Strata Critical Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.